Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025. MINS is a ...
Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing. HealthDay News — Ivabradine lowers heart rate (HR) and relieves symptoms ...
(HealthDay News) — For patients with angina pectoris, ivabradine is associated with improvements in certain parameters of quality of life (QoL), according to a study published online in Circulation: ...
Please provide your email address to receive an email when new articles are posted on . Initiating ivabradine before discharge among patients with stabilized HF increased ivabradine use at 180 days ...
The heart-rate-lowering drug ivabradine significantly reduces the risk of cardiovascular death and hospitalisation for worsening heart failure when added to standard treatment in patients with heart ...
SILVER SPRING, MD — Response to the recent approval of the heart-rate–slowing drug ivabradine (Corlanor, Amgen) by the US Food and Drug Administration (FDA) has included cautious enthusiasm as well as ...
Use of the heart-rate lowering drug ivabradine can reduce the incidence of cardiovascular disease and death in patients with coronary artery disease and a high heart rate. These are the conclusions of ...
The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results